Volume 33, Issue 2 (May 2022)
Studies in Medical Sciences 2022, 33(2): 106-115 |
Back to browse issues page
Ethics code: IR.UMSU.REC.1398.293
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Herik Dizji M, Masoudi N, Rezaei S, Seyedmardani S, Pourjabali M. OSTEOPOROSIS FREQUENCY AND ITS RELATIONSHIP WITH SERUM LEVEL OF VITAMIN K2 IN COLON CANCER PATIENTS BEFORE AND AFTER COLECTOMY. Studies in Medical Sciences 2022; 33 (2) :106-115
URL: http://umj.umsu.ac.ir/article-1-5804-en.html
URL: http://umj.umsu.ac.ir/article-1-5804-en.html
Mohsen Herik Dizji 
, Naser Masoudi * , Seyfollah Rezaei , Seyedmostafa Seyedmardani , Masoumeh Pourjabali
, Naser Masoudi * , Seyfollah Rezaei , Seyedmostafa Seyedmardani , Masoumeh Pourjabali
Assistant Professor of General Surgery, Urmia University of Medical Sciences, Urmia, Iran (Corresponding author) , nasermasoudi1401@gmail.com
Abstract: (1975 Views)
Background & Aims: Colorectal cancer is one of the most common cancers of the gastrointestinal tract, caused by predisposing factors like lifestyle and aging, and partly, due to genetic and inherited disorders. Due to the increasing incidence of this cancer in Iran, the present study was designed to determine the prevalence of osteoporosis and its relationship with serum levels of vitamin K2 in the patients with colon cancer before and after colectomy.
Materials &Methods: In this descriptive-analytical study, 38 patients with colon cancer who underwent colectomy in Imam Khomeini Hospital in Urmia were included in the study.
Demographic information, BMD, and vitamin K2 levels of the patients before and after colectomy were collected and recorded in a checklist. Data were analyzed using SPSS Version 17 statistical software.
Results: From 38 patients with colorectal cancer, 34.2% were male and 65.8% were female. The mean age of the patients was 58.5 ± 12.7 years. Reviewing bone density examinations done by Dual Energy X-Ray Absorptiometry (DXA) in hip and spine of the patients showed that osteoporosis was higher in both places after colectomy, and their significant differences between them (P-Values were 0.043 for hip and P0.009 for spine).
Conclusion: The results of this study showed that osteoporosis in the hip and spine of the patients with colon cancer increased after colectomy compared to it before colectomy. However, the correlation between serum vitamin K2 levels and osteoporosis was not significant.
Materials &Methods: In this descriptive-analytical study, 38 patients with colon cancer who underwent colectomy in Imam Khomeini Hospital in Urmia were included in the study.
Demographic information, BMD, and vitamin K2 levels of the patients before and after colectomy were collected and recorded in a checklist. Data were analyzed using SPSS Version 17 statistical software.
Results: From 38 patients with colorectal cancer, 34.2% were male and 65.8% were female. The mean age of the patients was 58.5 ± 12.7 years. Reviewing bone density examinations done by Dual Energy X-Ray Absorptiometry (DXA) in hip and spine of the patients showed that osteoporosis was higher in both places after colectomy, and their significant differences between them (P-Values were 0.043 for hip and P0.009 for spine).
Conclusion: The results of this study showed that osteoporosis in the hip and spine of the patients with colon cancer increased after colectomy compared to it before colectomy. However, the correlation between serum vitamin K2 levels and osteoporosis was not significant.
Type of Study: Research |
Subject:
جراحی عمومی
References
1. Corman ML. Colon and Rectal surgery. 4th ed. New York: Lippincott company; 1999. p. 625- 762. [PMCID]
2. Becker N. Epidemiology of colorectal cancer. Radiologe 2003;43(2)98-104. [DOI:10.1007/s00117-003-0868-9] [PMID]
3. Wickham R, Lassere Y, editors. The ABCs of colorectal cancer. Seminars in oncology nursing; 2007: Elsevier. [DOI:10.1016/j.soncn.2006.08.001]
4. Society AC. Cancer facts & figures: The Society; 2008. [URL]
5. Ju J-H, Chang S-C, Wang H-S, Yang S-H, Jiang J-K, Chen W-C, et al. Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis 2007;22(8):855-62. [DOI:10.1007/s00384-007-0293-z] [PMID]
6. Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Japan J Clin Oncol 2009;39(3):189-91. [DOI:10.1093/jjco/hyn144] [PMID]
7. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Annals of oncology 2008;20(3):556-63. [DOI:10.1093/annonc/mdn642] [PMID]
8. Larijani B, Moayyeri A, Keshtkar AA, Hossein-Nezhad A, Soltani A, Bahrami A, et al. Peak bone mass of Iranian population: The Iranian Multicenter Osteoporosis Study. J Clin Densitom 2006;9(3):367-74. [DOI:10.1016/j.jocd.2006.05.001] [PMID]
9. Jamshidian-Tehrani M, Kalantari N, Azadbakht L, Esmaillzadeh A, Rajaie A, Houshiar-Rad A, et al. [Osteoporosis risk factors in Tehrani women aged 40-60 years]. Iran J Endocrinol Metabol 2004;6(2):139-45. (In Persian) [Google Scholar]
10. Pajouhi M, Komeylian Z, Sedaghat M, Baradar Jalili R, Soltani A, Larijani B. Efficacy of educational pamphlets for improvement of knowledge and practice in patients with Osteoporosis. Payesh 2004;1:67-74. (In Persian)
11. Handa R, Kalla AA, Maalouf G. Osteoporosis in developing countries. Best Pract Res Clin Rheumatol 2008;22(4):693-708. [DOI:10.1016/j.berh.2008.04.002] [PMID]
12. Schacht E. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcified Tissue Int 1999;65(4):317-27. [DOI:10.1007/s002239900705] [PMID]
13. Saadi H, Litaker D, Mills W, Kippes C, Richmond B, Licata A. Practice variation in the diagnosis and treatment of osteoporosis: a case for more effective physician education in primary care. J Women Health Gend Based Med 1999;8(6):767-71. [DOI:10.1089/152460999319093] [PMID]
14. Bonetto A, Kays JK, Parker VA, Matthews RR, Barreto R, Puppa MJ, et al. Differential bone loss in mouse models of colon cancer cachexia. Front Physiol 2017;7:679. [DOI:10.3389/fphys.2016.00679] [PMID] [PMCID]
15. Anderson F, Francis R, Selby P, Cooper C. Sex hormones and osteoporosis in men. Calcif Tissue Int 1998;62(3):185-8. [DOI:10.1007/s002239900414] [PMID]
16. Ganry O, Lapotre-Ledoux B, Fardellone P, Dubreuil A. Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women. Eur J Epidemiol 2008;23(7):467-73. [DOI:10.1007/s10654-008-9256-0] [PMID]
17. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. The Am J Med. 2009;122(7):599-604. [DOI:10.1016/j.amjmed.2009.01.022] [PMID] [PMCID]
18. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000;133(10):795-9. [DOI:10.7326/0003-4819-133-10-200011210-00012] [PMID]
19. Sakellariou GT, Moschos J, Berberidis C, Mpoumponaris A, Kadis S, Molyvas E, et al. Bone density in young males with recently diagnosed inflammatory bowel disease. Joint Bone Spine 2006;73(6):725-8. [DOI:10.1016/j.jbspin.2006.01.017] [PMID]
20. Hegarty JM, Yang H, Chi NC. UBIAD1-mediated vitamin K2 synthesis is required for vascular endothelial cell survival and development. Development 2013;140(8):1713-9. [DOI:10.1242/dev.093112] [PMID] [PMCID]
21. El Asmar MS, Naoum JJ, Arbid EJ. Vitamin K dependent proteins and the role of vitamin K2 in the modulation of vascular calcification: a review. Oman Med J 2014;29(3):172. [DOI:10.5001/omj.2014.44] [PMID] [PMCID]
22. Onodera K, Shinoda H, Zushida K, Taki K, Kamei J. Antinociceptive effect induced by intraperitoneal administration of vitamin K2 (menatetrenone) in ICR mice. Life Sci 2000;68(1):91-7. [DOI:10.1016/S0024-3205(00)00917-6] [PMID]
23. Oztopcu P, Kabadere S, Mercangoz A, Uyar R. Comparison of vitamins K~ 1, K~ 2 and K~ 3 effects on growth of rat glioma and human glioblastoma multiforme cells in vitro. Acta Neurol Belg 2004;104:106-10. [Google Scholar]
24. Conly J, Stein K. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med 1994;17(6):531. [Google Scholar]
25. Tasci A, Bilgili H, Altunay H, Gecit M, Keskin D. Prospective evaluation of Vitamin K2, Raloxifene and their co-administration in osteoporotic rats. Eur J Pharmaceut Sci 2011;43(4):270-7. [DOI:10.1016/j.ejps.2011.04.019] [PMID]
26. Hauschka PV, Lian JB, Cole D, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69(3):990-1047. [DOI:10.1152/physrev.1989.69.3.990] [PMID]
27. Urayama S, Kawakami A, Nakashima T, Tsuboi M, Yamasaki S, Hida A, et al. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine. J Lab Clin Med 2000;136(3):181-93. [DOI:10.1067/mlc.2000.108754] [PMID]
28. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S. Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J molecular End 2007;39(4):239-47. [DOI:10.1677/JME-07-0048] [PMID]
29. Huang Z-B, Wan S-L, Lu Y-J, Ning L, Liu C, Fan S-W. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials. Osteopo Int 2015;26(3):1175-86. [DOI:10.1007/s00198-014-2989-6] [PMID]
30. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 1991;90:107-10. [DOI:10.1016/0002-9343(91)90512-V] [PMID]
31. Binkley N C, Suttie JW. Vitamin K nutrition and osteoporosis. J Nutr 1995;125(2): 1812-21. [DOI:10.1093/jn/125.7.1812] [PMID]
32. Conway SP. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 2005;115:1325-31. [DOI:10.1542/peds.2004-1242] [PMID]
33. Stigliano S, Waldthaler A, Martinez-Moneo E, Lionetto L, Robinson S, Malvik M, et al. Vitamins D and K as Factors Associated with Osteopathy in Chronic Pancreatitis: A Prospective Multicentre Study (P-BONE Study). Clin Translat Gastroenterol 2018;9(10):197. [DOI:10.1038/s41424-018-0066-8] [PMID] [PMCID]
34. Gowda S, Lipka S, Davis-Yadley AH, Shen H, Silpe J, White A, et al. Low bone mineral density linked to colorectal adenomas: a cross-sectional study of a racially diverse population. J Gastrointest Oncol 2015;6(2):165. [PMCID]
35. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000;15(3):515-21. [DOI:10.1359/jbmr.2000.15.3.515] [PMID]
36. Shen B, Remzi FH, Oikonomou IK, Lu H, Lashner BA, Hammel JP, et al. Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol 2009;104(3):639-46.
https://doi.org/10.1038/ajg.2008.78 [DOI:10.14309/00000434-200903000-00023] [PMID]
37. Booth SL, Broe KE, Peterson JW, et al. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metabol 2004;89(10):4904-09. [DOI:10.1210/jc.2003-031673] [PMID]
38. Tsugawa N, Shiraki M, Suhara Y, et al. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Mineral Metabol 2008;26(1):79-85. [DOI:10.1007/s00774-007-0790-8] [PMID]
39. Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Mineral Res 1993;8(10):1241-5. [DOI:10.1002/jbmr.5650081012] [PMID]
40. Kodama Y, Okamoto Y, Kubota T, Hiroyama Y, Fukami H, Matsushita K, Kawano Y. Effectiveness of vitamin K2 on osteoporosis in adults with cerebral palsy. Brain Develop 2017;39(10):846-50. [DOI:10.1016/j.braindev.2017.05.012] [PMID]
41. Bonetto A, Kays JK, Parker VA, Matthews RR, Barreto R, Puppa MJ, et al. Differential bone loss in mouse models of colon cancer cachexia. Frontiers Physiol 2017;7:679. [DOI:10.3389/fphys.2016.00679] [PMID] [PMCID]
42. Ahmadieh H, Arabi A. Vitamins and bone health: Beyond calcium and vitamin D. Nutr Rev 2011; 69(4):584-98. [DOI:10.1111/j.1753-4887.2011.00372.x] [PMID]
43. Liu J, Curtis EM, Cooper C, Harvey NC. State of the art in osteoporosis risk assessment and treatment. J. Endocrinol. Investig 2019; 42(1):1149-64. [DOI:10.1007/s40618-019-01041-6] [PMID] [PMCID]
44. Marie PJ. Bone cell senescence: Mechanisms and perspectives. J Bone Miner Res 2014;29(5):1311-21. [DOI:10.1002/jbmr.2190] [PMID]
45. Martinez-Moneo E. Deficiency of fat-soluble vitamins in chronic pancreatitis: a systematic review and meta-analysis. Pancreatol 2016;16(1):988-94. [DOI:10.1016/j.pan.2016.09.008] [PMID]
46. Fusaro M, Mereu, MC, Aghi A, Iervasi G, Gallieni M. Vitamin K and bone. Clin. Cases Miner. Bone Metab 2017;14(1):200-6. [DOI:10.11138/ccmbm/2017.14.1.200] [PMID] [PMCID]
47. Fusaro M, Gallieni M, Porta C, Nickolas TL, Khairallah P. Correction to: Vitamin K e_ects in human health: New insights beyond bone and cardiovascular health. J Nephrol 2020;33:389-94.
https://doi.org/10.1007/s40620-019-00693-0 [DOI:10.1007/s40620-019-00685-0] [PMID]
48. Tsugawa N, Shiraki M. Vitamin K Nutrition and Bone Health. Nutrients 2020;12(1):1909-14. [] [PMID] [PMCID]
49. Fusaro M, Cianciolo G, Brandi ML, Ferrari S, Nickolas TL, Tripepi G, et al. Vitamin K and Osteoporosis. Nutr 2020;12(12):3625. [DOI:10.3390/nu12123625] [PMID] [PMCID]
50. Vermeer C, Jie KS, Knapen MH. Role of vitamin K in bone metabolism. Ann Rev Nutr 1995;15:1-22 [DOI:10.1146/annurev.nu.15.070195.000245] [PMID]
51. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Mineral Res 2000;15(3):515-21 [DOI:10.1359/jbmr.2000.15.3.515] [PMID]
52. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, Tanaka K, et al. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 2008;26:79-85. [DOI:10.1007/s00774-007-0790-8] [PMID]
53. Xin F, Takemitsu M, Atsuta Y. Effect of vitamin K(2) on lumbar vertebral bone: histomorphometric analyses in experimental osteoporotic rats. J Orthop Sci 2001;6:535-9. [DOI:10.1007/s007760100009] [PMID]
54. Mawatari T, Miura H, Higaki H, Moro-Oka T, Kurata K, Murakami T, et al. osteoprotegerin ligand. Nature 1999;402:304-9.
55. Miheller P, Muzes G, Hritz I, Lakatos G, Pregun I, Lakatos PL, et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis 2009;15:1656-62. [DOI:10.1002/ibd.20947] [PMID]
56. Ohsaki Y, Shirakawa H, Hiwatashi K, Furukawa Y, Mizutani T, Komai M. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006;70:926-32. [DOI:10.1271/bbb.70.926] [PMID]
57. Shea MK, Booth SL, Massaro JM, Jacques PF, D'Agostino RB Sr, Dawson-Hughes B, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008;167:313-20. [DOI:10.1093/aje/kwm306] [PMID] [PMCID]
58. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S. Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 2006;281:16927-34. [DOI:10.1074/jbc.M600896200] [PMID]
59. Van Etten E, Decallonne B, Verlinden L, Verstuyf A, Bouillon R, Mathieu C. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators. J Cell Biochem 2003;88:223-6. [DOI:10.1002/jcb.10329] [PMID]
60. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579-85. [DOI:10.1096/fj.01-0433rev] [PMID]
61. Hamidi MS, Cheung AM. Vitamin K and musculoskeletal health in postmenopausal women. Molecular Nutrition Food Res 2014;58(8):1647-1657. [DOI:10.1002/mnfr.201300950] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
